Do Women with Hyperthyroidism Need to Avoid Iodine During Pregnancy and Breastfeeding?

Women with Graves’ disease or other forms of hyperthyroidism often wonder whether they must avoid iodine during pregnancy and lactation. The answer is nuanced: routine iodine restriction is not recommended—and may even be harmful—during these periods.

During pregnancy, maternal iodine requirements increase by approximately 50% to support fetal thyroid hormone synthesis and neurodevelopment. The American Thyroid Association (ATA) recommends a daily iodine intake of 250 µg for pregnant individuals, primarily through iodized salt and prenatal vitamins containing potassium iodide. Restricting iodine unnecessarily can impair fetal brain development and increase the risk of congenital hypothyroidism.

For women with hyperthyroidism, the concern isn’t dietary iodine per se, but rather excessive iodine exposure—such as from supplements, seaweed, or radiographic contrast agents—which can transiently exacerbate thyroid hormone production via the Wolff–Chaikoff effect escape phenomenon. However, normal dietary iodine intake remains safe and essential. Antithyroid medications (e.g., propylthiouracil in the first trimester, methimazole thereafter) are the cornerstone of treatment; iodine restriction does not replace pharmacologic management.

During lactation, iodine continues to be vital for infant neurodevelopment and is actively secreted into breast milk. The ATA advises 250 µg/day for breastfeeding individuals. Most antithyroid drugs are compatible with nursing—propylthiouracil and methimazole both have low transfer into breast milk and are considered safe when used at standard therapeutic doses.

In summary, iodine avoidance is neither necessary nor advisable for most women with hyperthyroidism during pregnancy or breastfeeding. Instead, clinicians should emphasize consistent antithyroid therapy, appropriate iodine nutrition, and close monitoring of thyroid function throughout gestation and the postpartum period.